Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cannasat to commence phase Ib CAT-310 study for neuropathic pain

Jan. 30, 2009

Connexin43 mimetic peptide shows promise in spinal cord contusion injury model

Jan. 30, 2009

Roche divulges antipsychotic tachykinin NK3 receptor antagonists

Jan. 30, 2009

Chelsea initiates phase II droxidopa trial in fibromyalgia

Jan. 29, 2009

Cripto blockade enhances embryonic stem cell transplant in Parkinson's disease model

Jan. 29, 2009

Lipoic acid slows Alzheimer's disease progression

Jan. 29, 2009

Addex announces successful completion of phase I program of ADX-48621

Jan. 28, 2009

Orexo and NovaMed sign licensing and distribution agreement for Abstral in China

Jan. 28, 2009

MHRA grants approval to Cortex to initiate study of CX-1739 in sleep apnea

Jan. 28, 2009

GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model

Jan. 28, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...